Cite

HARVARD Citation

    Ladumor, M. et al. (2023). Predicting changes in the pharmacokinetics of CYP3A‐metabolized drugs in hepatic impairment and insights into factors driving these changes. CPT: pharmacometrics & systems pharmacology. pp. 261-273. [Online]. 
  
Back to record